Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

STRATA Skin Sciences (SSKN) Research & Development (2016 - 2025)

STRATA Skin Sciences' Research & Development history spans 13 years, with the latest figure at $172000.0 for Q3 2025.

  • For Q3 2025, Research & Development fell 29.22% year-over-year to $172000.0; the TTM value through Sep 2025 reached $711000.0, down 33.11%, while the annual FY2024 figure was $883000.0, 32.95% down from the prior year.
  • Research & Development for Q3 2025 was $172000.0 at STRATA Skin Sciences, up from $96000.0 in the prior quarter.
  • Across five years, Research & Development topped out at $441000.0 in Q4 2022 and bottomed at $96000.0 in Q1 2025.
  • The 5-year median for Research & Development is $245500.0 (2023), against an average of $273944.4.
  • The largest annual shift saw Research & Development surged 93.25% in 2023 before it tumbled 60.17% in 2025.
  • A 5-year view of Research & Development shows it stood at $276000.0 in 2021, then surged by 59.78% to $441000.0 in 2022, then decreased by 13.83% to $380000.0 in 2023, then crashed by 47.37% to $200000.0 in 2024, then dropped by 14.0% to $172000.0 in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Research & Development are $172000.0 (Q3 2025), $96000.0 (Q1 2025), and $200000.0 (Q4 2024).